182 related articles for article (PubMed ID: 18306923)
21. Updates on human papillomavirus and genital warts and counseling messages from the 2010 Sexually Transmitted Diseases Treatment Guidelines.
Dunne EF; Friedman A; Datta SD; Markowitz LE; Workowski KA
Clin Infect Dis; 2011 Dec; 53 Suppl 3():S143-52. PubMed ID: 22080267
[TBL] [Abstract][Full Text] [Related]
22. [Genital papillomavirus infections].
Laurent R
Rev Prat; 1996 Oct; 46(16):1961-8. PubMed ID: 8978202
[TBL] [Abstract][Full Text] [Related]
23. Genital papillomavirus infections: current knowledge and future prospects.
Koutsky LA; Wølner-Hanssen P
Obstet Gynecol Clin North Am; 1989 Sep; 16(3):541-64. PubMed ID: 2556673
[TBL] [Abstract][Full Text] [Related]
24. The occurrence of genital types of human papillomavirus in normal pregnancy and in pregnant renal transplant recipients.
Gajewska M; Wielgos M; Kamiński P; Marianowski P; Malejczyk M; Majewski S; Marianowski L
Neuro Endocrinol Lett; 2006 Aug; 27(4):529-34. PubMed ID: 16891989
[TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus: burden of illness and treatment cost considerations.
Fox PA; Tung MY
Am J Clin Dermatol; 2005; 6(6):365-81. PubMed ID: 16343025
[TBL] [Abstract][Full Text] [Related]
26. Genitoanal human papillomavirus infection and associated neoplasias.
Gross G
Curr Probl Dermatol; 2014; 45():98-122. PubMed ID: 24643181
[TBL] [Abstract][Full Text] [Related]
27. Intraurethral condylomata acuminata associated with genital piercings.
Takahashi S; Hirano Y; Kawamura T; Homma Y
Int J STD AIDS; 2013 Jan; 24(1):67-9. PubMed ID: 23512508
[TBL] [Abstract][Full Text] [Related]
28. Global burden of human papillomavirus and related diseases.
Forman D; de Martel C; Lacey CJ; Soerjomataram I; Lortet-Tieulent J; Bruni L; Vignat J; Ferlay J; Bray F; Plummer M; Franceschi S
Vaccine; 2012 Nov; 30 Suppl 5():F12-23. PubMed ID: 23199955
[TBL] [Abstract][Full Text] [Related]
29. High-grade dysplasia in genital warts from two patients infected with the human immunodeficiency virus.
Bryan JT; Stoler MH; Tyring SK; McClowry T; Fife KH; Brown DR
J Med Virol; 1998 Jan; 54(1):69-73. PubMed ID: 9443111
[TBL] [Abstract][Full Text] [Related]
30. HPV-6 Molecular Variants Association With the Development of Genital Warts in Men: The HIM Study.
Flores-Díaz E; Sereday KA; Ferreira S; Sirak B; Sobrinho JS; Baggio ML; Galan L; Silva RC; Lazcano-Ponce E; Giuliano AR; Villa LL; Sichero L;
J Infect Dis; 2017 Feb; 215(4):559-565. PubMed ID: 28011919
[TBL] [Abstract][Full Text] [Related]
31. [Clinical and benign aspects of human papillomavirus-associated lesions].
Aubin F; Guerrini JS
Bull Acad Natl Med; 2007 Mar; 191(3):585-97; discussion 597-9. PubMed ID: 18072655
[TBL] [Abstract][Full Text] [Related]
32. [Human papilloma virus (HPV) infections of the uterine cervix, vagina and vulva in women of childbearing age].
Basta A; Strama M; Pityński K; Kielar B; Gudynudis E
Ginekol Pol; 1994 Oct; 65(10):563-9. PubMed ID: 7729716
[TBL] [Abstract][Full Text] [Related]
33. [Papillomavirus-induced anogenital lesions in 121 HIV seropositive men. Clinical, histological, viral study, and evolution].
Voltz JM; Drobacheff C; Derancourt C; Coumes-Marquet S; Mougin C; Laurent R
Ann Dermatol Venereol; 1999 May; 126(5):424-9. PubMed ID: 10434106
[TBL] [Abstract][Full Text] [Related]
34. Treatment of genital warts - what's the evidence?
Wilson J
Int J STD AIDS; 2002 Apr; 13(4):216-20; quiz 221-2. PubMed ID: 11886604
[TBL] [Abstract][Full Text] [Related]
35. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine.
Garland SM; Steben M; Sings HL; James M; Lu S; Railkar R; Barr E; Haupt RM; Joura EA
J Infect Dis; 2009 Mar; 199(6):805-14. PubMed ID: 19199546
[TBL] [Abstract][Full Text] [Related]
36. Issues in the management of human papillomavirus genital disease.
Verdon ME
Am Fam Physician; 1997 Apr; 55(5):1813-6, 1819, 1822. PubMed ID: 9105207
[TBL] [Abstract][Full Text] [Related]
37. Spotlight on quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine(Gardasil®) in the prevention of premalignant genital lesions, genital cancer, and genital warts in women.
McCormack PL; Joura EA
BioDrugs; 2011 Oct; 25(5):339-43. PubMed ID: 21942919
[TBL] [Abstract][Full Text] [Related]
38. Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination.
Östensson E; Fröberg M; Leval A; Hellström AC; Bäcklund M; Zethraeus N; Andersson S
PLoS One; 2015; 10(9):e0139062. PubMed ID: 26398189
[TBL] [Abstract][Full Text] [Related]
39. The impact of human papillomavirus (HPV) types 6, 11 in women with genital warts.
Jamshidi M; Shekari M; Nejatizadeh AA; Malekzadeh K; Baghershiroodi M; Davudian P; Dehghan F; Jamshidi F
Arch Gynecol Obstet; 2012 Nov; 286(5):1261-7. PubMed ID: 22718097
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of human papilloma virus genital infections in sexually transmitted diseases clinic attendees in Ibadan.
Okesola AO; Fawole OI
West Afr J Med; 2000; 19(3):195-9. PubMed ID: 11126083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
